The next generation of drugs for treating lung disease can only be effective if they are properly administered.
Conventional inhalers and nebulisers are not up to the task, meaning the new drugs could only be administered in a hospital or medical practitioner's office. Traditional inhalers require hand-breath coordination to use. The patient needs to be trained and this often results in misuse, especially in the very young or elderly. Nebulisers are more reliable, but the models currently available are unable to deliver the heavy molecules that feature in all next generation treatments.
Our researchers have developed a new kind of nebuliser that will be cheaper and more effective than any currently available. The new nebuliser uses sound waves to excite the surface of the fluid. This method generates a fine mist capable of delivering much larger molecules directly to the lungs. The low power requirement means the nebulisers will be as cheap and portable as they are effective.
The device is currently being tested to measure its performance against a range of lung conditions.